Challenges in drug discovery for neurofibromatosis type 1-associated low-grade glioma

Authors

Cora A. Ricker, Children’s Cancer Therapy Development Institute
Yuan Pan, Washington University School of Medicine in St. Louis
David H. Gutmann, Washington University School of Medicine in St. Louis
Charles Keller, Children’s Cancer Therapy Development Institute

Journal

Frontiers in Oncology

Publication Date

2016

Volume

6

Inclusive Pages

259

Document Type

Open Access Publication

DOI

10.3389/fonc.2016.00259

Rights and Permissions

Ricker CA, Pan Y, Gutmann DH and Keller C (2016) Challenges in Drug Discovery for Neurofibromatosis Type 1-Associated Low-Grade Glioma. Front. Oncol. 6:259. doi: 10.3389/fonc.2016.00259 Copyright: © 2016 Ricker, Pan, Gutmann and Keller. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Recommended Citation

Ricker, Cora A.; Pan, Yuan; Gutmann, David H.; and Keller, Charles, "Challenges in drug discovery for neurofibromatosis type 1-associated low-grade glioma." Frontiers in Oncology. 6, 259. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/5538